Article
An inducible transgenic mouse model for familial hypertension with hyperkalaemia (Gordon's syndrome or pseudohypoaldosteronism type II).
Clinical science (London, England : 1979) - 1 Jun 2013
Chowdhury Jabed A, Liu Che-Hsiung, Zuber Annie M, O'Shaughnessy Kevin M
Abstract excerpt
Mutations in the novel serine/threonine WNK [With No lysine (=K)] kinases WNK1 and WNK4 cause PHAII (pseudohypoaldosteronism type II or Gordon's syndrome), a rare monogenic syndrome which causes hypertension and hyperkalaemia on a background of a normal glomerular filtration rate. Current animal models for PHAII recapitulate some aspects of the disease phenotype, but give no clues to how rapidly the phenotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
